OTC Markets OTCQB - Delayed Quote USD

Izotropic Corporation (IZOZF)

Compare
0.0530 0.0000 (0.00%)
As of October 31 at 4:00 PM EDT. Market Open.
Loading Chart for IZOZF
DELL
  • Previous Close 0.0426
  • Open 0.0426
  • Bid 0.0421 x --
  • Ask 0.0582 x --
  • Day's Range 0.0426 - 0.0426
  • 52 Week Range 0.0310 - 0.1780
  • Volume 300
  • Avg. Volume 51,750
  • Market Cap (intraday) 3.01M
  • Beta (5Y Monthly) 1.86
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date Dec 30, 2024 - Jan 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

izocorp.com

--

Full Time Employees

April 30

Fiscal Year Ends

Recent News: IZOZF

View More

Performance Overview: IZOZF

Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IZOZF
32.05%
S&P/TSX Composite index
16.16%

1-Year Return

IZOZF
62.14%
S&P/TSX Composite index
28.99%

3-Year Return

IZOZF
93.45%
S&P/TSX Composite index
15.72%

5-Year Return

IZOZF
94.65%
S&P/TSX Composite index
34.93%

Compare To: IZOZF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IZOZF

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    2.45M

  • Enterprise Value

    3.85M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -412.72%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -2.35M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    102.05k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -716.77k

Research Analysis: IZOZF

View More

Company Insights: IZOZF

Research Reports: IZOZF

View More

People Also Watch